LA JOLLA

RB Capital Partners, Inc. Officially Moves Forward with Appointment of a Receiver for Optec International, Inc.

Retrieved on: 
火曜日, 2月 27, 2024
SAN, Social media, IBN, Rehabilitation, Security (finance)

SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – RB Capital Partners, Inc., a judgment creditor against Optec International Inc. (OTCPink: OPTI) (“Optec”), announces it has engaged Mark Basile and The Basile Law Firm P.C.

Key Points: 
  • SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – RB Capital Partners, Inc., a judgment creditor against Optec International Inc. (OTCPink: OPTI) (“Optec”), announces it has engaged Mark Basile and The Basile Law Firm P.C.
  • to work with the courts to officially appoint a receiver to run Optec in the interim while a new company is merged into the public vehicle.
  • As the largest investor and legitimate shareholder of Optec International, Inc., RB Capital was forced to bring a shareholder derivative action against Optec to secure the company’s judgment, oust the failing Roger Pawson, and to try to preserve Optec’s assets.
  • In order to promote transparency, RB Capital commits to making consistent updates about Optec via press releases and social media posts.

Turnstone Biologics to Participate in Upcoming Investor Conferences

Retrieved on: 
水曜日, 2月 21, 2024
SAN, Selection, Patient

SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced that members of its senior management team will participate in the following investor conferences:

Key Points: 
  • SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced that members of its senior management team will participate in the following investor conferences:

Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.

Retrieved on: 
火曜日, 2月 20, 2024
Friends, SAN, Selection, Sadness, Patient, Family, Cancer

Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, commented, “This is a moment of profound sadness for those of us who had the privilege of knowing Joseph.

Key Points: 
  • Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, commented, “This is a moment of profound sadness for those of us who had the privilege of knowing Joseph.
  • Joseph will be deeply remembered for his remarkable passion, intellectual curiosity, exemplary character and integrity, and unwavering dedication to improving the lives of people living with cancer.
  • On behalf of the entire Turnstone team, I would like to extend our sincerest sympathies to Joseph’s family and loved ones.”
    Dr. Farah continued, “With Joseph’s passing, Turnstone has suffered a great loss.
  • However, the Company is confident that the rest of the management team will continue to lead Turnstone forward and capitalize on the legal and compliance principles that Joseph established at Turnstone."

Sam Edelman Collaborates with SCAD on Exclusive Capsule Collection for Nordstrom

Retrieved on: 
火曜日, 3月 5, 2024
Men, Online Retail, Other Retail, Luxury, Lifestyle, Department Stores, Specialty, Consumer, Fashion, Retail, Women, Footwear, Collection, Student, Mall, Multimedia, Coral Gables, Florida, UTC, Merrick Park, Art, Photography, Human, SCAD, CAL, Partnership, Department store

View the full release here: https://www.businesswire.com/news/home/20240305000484/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240305000484/en/
    Sam Edelman Collaborates with SCAD on Exclusive Capsule Collection for Nordstrom (Photo: Business Wire)
    In celebration of Nordstrom’s “Make Room for Shoes” campaign and rich shoe history, dating back to 1901, the Sam Edelman x SCAD capsule collection delivers innovative and exclusive products centered around the emerging trends for the season.
  • “Mentoring the next generation of talent is a cornerstone of Sam Edelman's commitment to the future of design,” remarked Jesse Edelman, general manager and senior vice president of the Sam Edelman division.
  • Sam and Libby spent time at SCAD, working with the students to create this collection of sneakers through an unrestrained, imaginative approach to women’s and kids’ sneaker design.
  • “Working with Sam Edelman and Libby on this project was nothing short of amazing,” remarked Michael Mack, SCAD professor of sneaker and accessory design who led the course.

Palomar Holdings, Inc. Reports Fourth Quarter & Full Year 2023 Results

Retrieved on: 
水曜日, 2月 14, 2024
Investment, Growth, Conference, Eastern Time Zone, Insurance

Mac Armstrong, Chairman and Chief Executive Officer, commented, "The fourth quarter provided a strong end to what was a stellar 2023.

Key Points: 
  • Mac Armstrong, Chairman and Chief Executive Officer, commented, "The fourth quarter provided a strong end to what was a stellar 2023.
  • There were no share repurchases in the current quarter and as of December 31, 2023, $43.5 million remains available for future repurchases.
  • As previously announced, Palomar will host a conference call Thursday, February 15, 2024, to discuss its fourth quarter 2023 results at 12:00 p.m. (Eastern Time).
  • The conference call can be accessed live by dialing 1-877-423-9813 or for international callers, 1-201-689-8573, and requesting to be joined to the Palomar Fourth Quarter 2023 Earnings Conference Call.

Truepic and SmartFrame Partner to Deliver Landmark Authenticity and Transparency to Global Sports Brands

Retrieved on: 
火曜日, 2月 13, 2024
SAN, C2PA, Coalition, SmartFrame, Manchester City F.C., Advertising, Six Nations Championship, Trust, Partnership, Online shopping

SmartFrame, with its innovative image-streaming technology, has made substantial strides in ensuring the integrity and ownership of media collections.

Key Points: 
  • SmartFrame, with its innovative image-streaming technology, has made substantial strides in ensuring the integrity and ownership of media collections.
  • Recognizing the importance of ensuring transparency and authenticity online, multiple sports enterprises and brands, such as Six Nations Rugby , New Zealand Rugby , and Manchester City F.C.
  • “SmartFrame and Truepic’s partnership represents a significant leap forward in digital media integrity,” said Jeffrey McGregor, CEO of Truepic.
  • We are proud to partner with a forward-thinking organization like SmartFrame on industry leading content integrity products.

RB Capital Partners, Inc. Announces Shareholder Update for Optec International, Inc.

Retrieved on: 
月曜日, 2月 12, 2024
SAN, IBN, OPTEC, Judgement, Pawson, Security (finance)

SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – RB Capital Partners, Inc., a judgment creditor against OPTEC INTERNATIONAL, INC. (OTCPink: OPTI) would like to clarify the judgment it obtained against the mismanaged company and its prior failed CEO, Roger Pawson.

Key Points: 
  • SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – RB Capital Partners, Inc., a judgment creditor against OPTEC INTERNATIONAL, INC. (OTCPink: OPTI) would like to clarify the judgment it obtained against the mismanaged company and its prior failed CEO, Roger Pawson.
  • As the largest investor and legitimate shareholder of OPTEC, we were forced to bring a shareholder derivative action against the company to secure our judgment, oust the failing Roger Pawson and to try to preserve the assets of the company.
  • We would also like to thank Mark Basile and all the amazing attorneys at The Basile Law Firm P.C.
  • To date we have not sought the appointment of a receiver as we weigh the benefits of doing so and RB Capital Partners, Inc., nor any of its members, are an officer or director of Optec International, Inc.

Palomar Holdings, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results Release Date and Conference Call

Retrieved on: 
水曜日, 2月 7, 2024
Eastern Time Zone, Conference

The conference call can be accessed live by dialing 1-877-423-9813 or for international callers,1-201-689-8573, and requesting to be joined to the Palomar Fourth Quarter 2023 Earnings Conference Call.

Key Points: 
  • The conference call can be accessed live by dialing 1-877-423-9813 or for international callers,1-201-689-8573, and requesting to be joined to the Palomar Fourth Quarter 2023 Earnings Conference Call.
  • A replay will be available starting at 4:00 p.m. (Eastern Time) on February 16, 2024, and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671.
  • The replay will be available until 11:59 p.m. (Eastern Time) on February 22, 2024.
  • The online replay will remain available for a limited time beginning immediately following the call.

Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform

Retrieved on: 
月曜日, 2月 5, 2024
SAN, G4S, RNA, Genome Biology, OMIC, Proteomics, Tissue, NGS, F4, Medical imaging

Singular unveiled the G4X™ Spatial Sequencer as a high-throughput in situ spatial sequencing platform capable of simultaneous direct RNA sequencing, targeted transcriptomics, proteomics and fluorescent H&E from formalin-fixed, paraffin-embedded (FFPE) tissues.

Key Points: 
  • Singular unveiled the G4X™ Spatial Sequencer as a high-throughput in situ spatial sequencing platform capable of simultaneous direct RNA sequencing, targeted transcriptomics, proteomics and fluorescent H&E from formalin-fixed, paraffin-embedded (FFPE) tissues.
  • As an upgrade to the G4® Sequencing Platform, the G4X is expected to position Singular to be the only company worldwide to offer capabilities for tissue-based in situ spatial multiomics and NGS on the same instrument.
  • The G4X Spatial Sequencer is on display at the conference, alongside performance data from technology access collaborations with top academic centers.
  • Singular also announced updates to the G4, the industry-leading benchtop sequencing system for speed, flexibility, and power.

Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis

Retrieved on: 
月曜日, 2月 5, 2024
Genomics, Tumor microenvironment, SAN, Protein, Workflow, Cell, RNA, Gene editing, Research, PX, Bone marrow, Haematopoietic system, OMIC, AML, Harvard Medical School, Proteomics, Associate professor, NGS, Tissue, Acute leukemia, Network throughput, Medical imaging

The G4X is designed to offer high-throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues.

Key Points: 
  • The G4X is designed to offer high-throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues.
  • The G4X Spatial Sequencer is designed to offer novel capabilities, stackable data streams, and unprecedented throughput for spatial profiling of tissue.
  • Its novel capabilities will include Direct-Seq, which is the sequencing of RNA molecules in situ and has the potential to open new areas of scientific discovery.
  • Singular also plans to provide G4X Spatial Sequencing Technology Access Services starting in the second quarter of 2024.